Clinical Trials Directory

Trials / Completed

CompletedNCT00002459

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Phase III Randomized Study of Adjuvant Pelvic Radiotherapy Versus Observation Alone in Patients With Completely Resected, Stage I or II, High-Grade Uterine Sarcoma

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
224 (actual)
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC · Network
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether receiving radiation therapy or no further therapy after surgery is more effective for cancer of the uterus. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with that of no further therapy in treating patients who have stage I or stage II cancer of the uterus that has been surgically removed.

Detailed description

OBJECTIVES: I. Compare the rates of pelvic recurrence and development of distant metastases in patients with completely resected, stage I or II, high-grade uterine sarcoma treated with adjuvant pelvic radiotherapy vs observation alone. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to center, tumor histology (leiomyosarcoma vs mixed mesodermal sarcoma vs endometrial stromal sarcoma), and surgical procedure (total abdominal hysterectomy (TAH) with or without bilateral salpingo-oophorectomy (BSO) vs TAH and BSO with pelvic and para-aortic node sampling and random biopsies). Patients are randomized to 1 of 2 treatment arms. Arm I: Beginning within 6 weeks after surgery, patients undergo pelvic radiotherapy 5 days a week for 5.6 weeks. Arm II: Patients undergo observation alone. Patients are followed every 2 months for 1 year, every 3 months for 2 years, and then every 6 months thereafter. PROJECTED ACCRUAL: A total of 200 patients (100 per arm) will be accrued for this study within 3 years.

Conditions

Interventions

TypeNameDescription
RADIATIONradiation therapy

Timeline

Start date
1988-04-01
Primary completion
2001-08-01
First posted
2004-03-11
Last updated
2012-09-24

Locations

28 sites across 10 countries: Belgium, Canada, France, Italy, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT00002459. Inclusion in this directory is not an endorsement.